CRBU Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $1.22

Piyasa Değeri (MRQ) $129M

P/E (TTM) -1.1

Hisse Başına Kâr (TTM) $-1.08

Gelir (TTM) $10M

ROE (TTM) -78.3%

52 Haftlık Aralık $1–$4

CRBU Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$11M

2019-12-31 → 2025-12-31

Hisse Başına Kâr$-1.59

2021-12-31 → 2025-12-31

Serbest Nakit Akışı$-112M

2021-12-31 → 2025-12-31

Net kar marjı-1030.4%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	CRBU	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-1.15Y ort. ≈-3.4	≈-3.4	·	·
F/S (TTM)	12.95Y ort. ≈33.1	≈33.1	40.4	Düşük değerli
F/D (MRQ)	1.35Y ort. ≈1.4	≈1.4	2.4	Düşük değerli
Fiyat / Serbest Nakit Akışı (TTM)	-1.45Y ort. ≈-7.5	≈-7.5	·	·
Fiyat / Nakit Akışı (TTM)	-1.45Y ort. ≈-8.0	≈-8.0	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	1.05Y ort. ≈1.4	≈1.4	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	CRBU	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-1090.9%5Y ort. ≈-959.8%	≈-959.8%	-3077.6%	En üst düzey
FAVÖK Marjı (TTM)	-1065.1%5Y ort. ≈-939.0%	≈-939.0%	-3077.6%	En üst düzey
Pretax Margin (Vergi Öncesi Kar Marjı)	-1332.3%5Y ort. ≈-906.2%	≈-906.2%	-3779.8%	En üst düzey
Net Kâr Marjı (TTM)	-1030.4%5Y ort. ≈-906.1%	≈-906.1%	-3650.4%	En üst düzey
ROA (TTM)	-56.9%5Y ort. ≈-35.7%	≈-35.7%	-66.8%	Aynı seviyede
ROE (TTM)	-78.3%5Y ort. ≈-46.8%	≈-46.8%	-108.3%	Aynı seviyede
ROIC	-121.0%5Y ort. ≈-54.2%	≈-54.2%	-98.3%	Ortalamanın altında

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	CRBU	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		6.55Y ort. ≈9.8	≈9.8	4.2	Güçlü likidite
Quick Ratio (Cari Oran)		0.55Y ort. ≈2.9	≈2.9	1.7	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	CRBU	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	11.7%5Y ort. ≈22.3%	≈22.3%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	-7.0%5Y ort. ≈11.7%	≈11.7%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	-2.0%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	CRBU	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-1.595Y ort. ≈$-1.67	≈$-1.67	·	·
Revenue / Share (Hisse Başına Gelir)	$0.125Y ort. ≈$0.23	≈$0.23	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-1.195Y ort. ≈$-1.37	≈$-1.37	·	·
Cash / Share (Hisse Başına Nakit)	$0.135Y ort. ≈$1.17	≈$1.17	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	CRBU	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.05Y ort. ≈0.0	≈0.0	0.0	En üst düzey
Receivables Turnover (Alacak Devir Hızı)	66.85Y ort. ≈69.5	≈69.5	4.7	En üst düzey
Revenue / Employee (Çalışan Başına Gelir)	≈$115.0K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 5.8%

Sonraki Rapor Kas 09, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 13, 2026	$-0.24	$-0.32	25.7%
31 Mart 2026		$-0.26	$-0.32	19.8%
31 Aralık 2025		$-0.28	$-0.32	11.4%
30 Eylül 2025		$-0.30	$-0.37	18.4%
30 Haziran 2025		$-0.58	$-0.40	-45.1%
31 Mart 2025		$-0.43	$-0.45	4.7%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 15

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$11M	$10M	$34M	$14M	$10M	$12M
R&D Expense	$109M	$130M	$112M	$82M	$52M	$34M
SG&A Expense	$38M	$46M	$38M	$38M	$24M	$14M
Operating Expenses	$160M	$177M	$151M	$120M	$77M	$48M
Operating Income	$-148M	$-167M	$-116M	$-106M	$-67M	$-36M
Interest Expense	·	·	·	·	$8.0K	$20.0K
Other Non-op	$-331.0K	$18M	$14M	$7M	$377.0K	$-3.0K
Pretax Income	$-149M	$-149M	$-102M	$-99M	$-67M	$-36M
Income Tax	$-550.0K	$-9.0K	$193.0K	$70.0K	$321.0K	$-2M
Net Income	$-148M	$-149M	$-102M	$-99M	$-67M	$-34M
EPS (Basic)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
EPS (Diluted)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·
Shares (Basic)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
Shares (Diluted)	93,389,283	90,317,925	73,807,597	60,801,133	31,663,243	·
EBITDA	$-145M	$-163M	$-113M	$-105M	$-66M	·

Bilanço 23

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$12M	$16M	$51M	$58M	$240M	$16M
Short-term Investments	·	·	·	·	$135M	$0
Receivables	$69.0K	$265.0K	$148.0K	$202.0K	$1M	$150.0K
Prepaid Expense	$3M	$7M	$6M	$8M	$7M	$3M
Current Assets	$145M	$219M	$339M	$260M	$391M	$24M
PP&E (Net)	$7M	$19M	$18M	$11M	$5M	$4M
PP&E (Gross)	$20M	$32M	$27M	$16M	$9M	$7M
Accum. Depreciation	$14M	$13M	$9M	$6M	$4M	$3M
Other Non-current Assets	$2M	$6M	$2M	$2M	$975.0K	$612.0K
Total Assets	$175M	$313M	$432M	$374M	$442M	$36M
Accounts Payable	$6M	$2M	$3M	$1M	$4M	$3M
Accrued Liabilities	$17M	$24M	$21M	$16M	$13M	$9M
Current Liabilities	$25M	$31M	$28M	$28M	$26M	$12M
Capital Leases	$26M	$25M	$26M	$27M	$0	·
Deferred Tax	$0	$548.0K	$557.0K	$381.0K	$476.0K	$155.0K
Total Liabilities	$53M	$60M	$64M	$73M	$55M	$18M
Common Stock	$9.0K	$9.0K	$8.0K	$6.0K	$6.0K	$1.0K
Paid-in Capital	$719M	$701M	$668M	$500M	$486M	$7M
Retained Earnings	$-597M	$-448M	$-299M	$-197M	$-98M	$-31M
AOCI	$103.0K	$255.0K	$30.0K	$-2M	$-135.0K	$0
Stockholders' Equity	$122M	$253M	$368M	$301M	$388M	$-23M
Liabilities + Equity	$175M	$313M	$432M	$374M	$442M	$36M
Shares Outstanding	95,143,690	92,378,577	88,448,948	61,029,184	60,263,158	9,710,829

Nakit Akışı 14

Metrik	2025	2024	2023	2022	2021	2020
D&A	$4M	$4M	$4M	$2M	$984.0K	$900.0K
Stock-based Comp	$13M	$17M	$14M	$12M	$3M	$1M
Deferred Tax	$-551.0K	$-10.0K	$178.0K	$-95.0K	$320.0K	$-919.0K
Other Non-cash	$21M	$-10M	$-9M	$-5M	$30M	·
Operating Cash Flow	$-111M	$-138M	$-93M	$-91M	$-33M	$-33M
CapEx	$1M	$5M	$12M	$6M	$2M	$317.0K
Investing Cash Flow	$102M	$87M	$-68M	$-93M	$-176M	$6M
Stock Issued	$4M	$15M	$1M	$0	·	·
Net Stock Activity	$4M	$15M	$1M	·	·	·
Financing Cash Flow	$5M	$17M	$154M	$2M	$433M	$2M
Net Change in Cash	$-4M	$-35M	$-7M	$-182M	$225M	$-25M
Taxes Paid	·	$0	$170.0K	$0	$11.0K	$21.0K
Free Cash Flow	$-112M	$-143M	$-105M	$-97M	$-35M	·
Levered FCF	·	·	·	·	$-35M	·

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020
Operating Margin	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%	·
Net Margin	-1327.4%	-1491.9%	-296.1%	-717.8%	-697.3%	·
Pretax Margin	-1332.3%	-1492.0%	-295.5%	-717.3%	-693.9%	·
EBITDA Margin	-1296.7%	-1627.9%	-326.4%	-756.5%	-687.6%	·
ROA	-60.6%	-40.0%	-25.3%	-24.4%	-28.0%	·
ROE	-102.8%	-55.8%	-26.6%	-31.8%	-16.9%	·
ROIC	-121.0%	-65.9%	-31.6%	-35.4%	-17.3%	·

Likidite ve Solventlik 3

Metrik	2025	2024	2023	2022	2021	2020
Current Ratio	5.7	7.2	12.0	9.3	15.1	·
Quick Ratio	0.5	0.5	1.8	2.1	9.4	·
Interest Coverage	·	·	·	·	-8372.4	·

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.0	0.1	0.0	0.0	·
Receivables Turnover		66.8	48.4	197.0	20.4	14.7	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$1.28	$2.74	$4.17	$4.93	$6.44	·
Revenue / Share	$0.12	$0.11	$0.47	$0.23	·	·
Cash Flow / Share	$-1.19	$-1.53	$-1.26	$-1.50	·	·
Cash / Share	$0.13	$0.18	$0.58	$0.96	$3.99	·
EPS (TTM)	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020
Revenue YoY	11.7%	-71.0%	148.9%	44.3%	-22.4%	·
Revenue CAGR 3Y	-7.0%	1.4%	40.8%	·	·	·
Revenue CAGR 5Y	-2.0%	·	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$11M	$10M	$34M	$14M	$10M	·
Net Income TTM	$-148M	$-149M	$-102M	$-99M	$-67M	·
Market Cap	$151M	$147M	$507M	$383M	$909M	·
P/E	-1.0	-1.0	-4.2	-3.8	-7.2	·
P/S	13.6	14.7	14.7	27.7	94.7	·
P/B	1.2	0.6	1.4	1.3	2.3	·
P / Tangible Book	1.2	0.6	1.4	1.3	2.3	·
P / Cash Flow	-1.4	-1.1	-5.4	-4.2	-28.0	·
P / FCF	-1.3	-1.0	-4.8	-3.9	-26.3	·
Earnings Yield	-100.0%	-103.8%	-24.1%	-26.1%	-14.0%	·

Gelir Tablosu 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1M	$2M	$4M	$2M	$3M	$2M	$2M	$2M	$3M	$2M	$4M	$24M	$4M	$4M	$4M	$3M
R&D Expense	$19M	$21M	$24M	$22M	$28M	$36M	$30M	$30M	$35M	$34M	$31M	$29M	$27M	$26M	$26M	$20M
SG&A Expense	$8M	$8M	$9M	$9M	$10M	$10M	$10M	$10M	$11M	$15M	$10M	$10M	$10M	$9M	$9M	$10M
Operating Expenses	$27M	$29M	$32M	$32M	$50M	$45M	$41M	$40M	$47M	$48M	$41M	$38M	$37M	$35M	$34M	$30M
Operating Income	$-25M	$-26M	$-28M	$-29M	$-48M	$-43M	$-39M	$-38M	$-44M	$-46M	$-37M	$-15M	$-33M	$-31M	$-31M	$-27M
Other Non-op	$1M	$1M	$1M	$2M	$-7M	$3M	$3M	$4M	$6M	$5M	$3M	$5M	$3M	$3M	$4M	$-110.0K
Income Tax	·	$0	$-550.0K	$0	·	$0	$-9.0K	$0	$0	$0	$193.0K	$0	$0	$0	$70.0K	$0
Net Income	$-24M	$-25M	$-26M	$-28M	$-54M	$-40M	$-35M	$-35M	$-38M	$-41M	$-35M	$-10M	$-30M	$-28M	$-27M	$-27M
EPS (Basic)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
EPS (Diluted)	$-0.24	$-0.26	$-0.28	$-0.30	$-0.58	$-0.43	$-0.39	$-0.38	$-0.42	$-0.46	$-0.32	$-0.12	$-0.48	$-0.46	$-0.44	$-0.44
Shares (Basic)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
Shares (Diluted)	100,985,698	95,861,716	·	93,293,099	93,028,698	92,679,493	·	90,455,900	90,340,932	89,302,937	·	83,783,992	61,417,934	61,186,514	·	60,886,921
EBITDA	$-25M	$-26M	·	$-29M	$-48M	$-42M	·	$-38M	$-44M	$-45M	·	$-15M	·	·	·	$-27M

Bilanço 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$26M	$12M	$12M	$11M	$25M	$29M	$16M	$32M	$38M	$49M	$51M	$104M	$66M	$53M	$58M	$82M
Receivables	$203.0K	$227.0K	$69.0K	$242.0K	$71.0K	$88.0K	$265.0K	$184.0K	$215.0K	$917.0K	$148.0K	$1M	$766.0K	$2M	$202.0K	$397.0K
Prepaid Expense	$2M	$2M	$3M	$5M	$6M	$6M	$7M	$7M	$6M	$7M	$6M	$7M	$6M	$6M	$8M	$9M
Current Assets	$117M	$122M	$145M	$156M	$193M	$217M	$219M	$237M	$271M	$305M	$339M	$351M	$269M	$239M	$260M	$307M
PP&E (Net)	$5M	$6M	$7M	$8M	$8M	$19M	$19M	$20M	$20M	$19M	$18M	$17M	$15M	$13M	$11M	$9M
PP&E (Gross)	$20M	$20M	$20M	$20M	$20M	$33M	$32M	$31M	$31M	$29M	$27M	$25M	$22M	$19M	$16M	$14M
Accum. Depreciation	$15M	$14M	$14M	$13M	$12M	$14M	$13M	$12M	$11M	$10M	$9M	$8M	$7M	$6M	$6M	$5M
Other Non-current Assets	$2M	$2M	$2M	$4M	$4M	$5M	$6M	$5M	$2M	$2M	$2M	$2M	$1M	$1M	$2M	$1M
Total Assets	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Accounts Payable	$3M	$4M	$6M	$4M	$3M	$4M	$2M	$3M	$3M	$6M	$3M	$2M	$4M	$3M	$1M	$1M
Accrued Liabilities	$13M	$14M	$17M	$19M	$21M	$20M	$24M	$25M	$24M	$19M	$21M	$18M	$16M	$13M	$16M	$15M
Current Liabilities	$18M	$20M	$25M	$28M	$29M	$28M	$31M	$32M	$31M	$29M	$28M	$25M	$34M	$27M	$28M	$29M
Capital Leases	$25M	$26M	$26M	$23M	$24M	$24M	$25M	$25M	$26M	$26M	$26M	$26M	$26M	$26M	$27M	$27M
Deferred Tax	·	·	$0	$548.0K	$548.0K	$548.0K	$548.0K	$557.0K	$557.0K	$556.0K	$557.0K	$381.0K	$380.0K	$382.0K	$381.0K	$475.0K
Total Liabilities	$45M	$47M	$53M	$53M	$55M	$56M	$60M	$63M	$62M	$64M	$64M	$59M	$80M	$69M	$73M	$75M
Common Stock	$11.0K	$10.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$9.0K	$8.0K	$8.0K	$6.0K	$6.0K	$6.0K	$6.0K
Paid-in Capital	$744M	$724M	$719M	$712M	$709M	$705M	$701M	$693M	$689M	$684M	$668M	$664M	$525M	$504M	$500M	$496M
Retained Earnings	$-646M	$-622M	$-597M	$-570M	$-542M	$-488M	$-448M	$-413M	$-378M	$-341M	$-299M	$-265M	$-255M	$-225M	$-197M	$-170M
AOCI	$-71.0K	$-23.0K	$103.0K	$93.0K	$40.0K	$167.0K	$255.0K	$789.0K	$-319.0K	$-322.0K	$30.0K	$-981.0K	$-1M	$-730.0K	$-2M	$-2M
Stockholders' Equity	$98M	$102M	$122M	$142M	$166M	$217M	$253M	$281M	$310M	$343M	$368M	$398M	$269M	$278M	$301M	$324M
Liabilities + Equity	$143M	$149M	$175M	$195M	$221M	$274M	$313M	$344M	$373M	$407M	$432M	$458M	$350M	$347M	$374M	$399M
Shares Outstanding	105,995,653	96,951,234	95,143,690	93,468,038	93,123,239	93,004,602	92,378,577	90,552,687	90,362,771	90,314,501	88,448,948	88,430,609	66,100,039	61,323,523	61,029,184	60,986,936

Nakit Akışı 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$625.0K	$649.0K	$682.0K	$631.0K	$1M	$1M	$1M	$1M	$856.0K	$710.0K	$740.0K	$2M	$617.0K	$589.0K	$506.0K	$450.0K
Stock-based Comp	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$4M	$5M	$4M	$4M	$3M	$4M	$3M	$3M	$3M
Restructuring	·	·	·	·	·	·	·	$600.0K	·	·	·	·	·	·	·	·
Other Non-cash	·	$-5M	·	·	·	$-2M	·	·	·	$-667.0K	·	·	·	·	·	·
Operating Cash Flow	$-23M	$-27M	$-21M	$-25M	$-28M	$-37M	$-35M	$-33M	$-33M	$-37M	$-21M	$-29M	$-15M	$-28M	$-25M	$-22M
CapEx	$1.0K	$72.0K	$-216.0K	$115.0K	$418.0K	$1M	$518.0K	$673.0K	$2M	$1M	$2M	$5M	$3M	$2M	$2M	$1M
Investing Cash Flow	$19M	$24M	$18M	$11M	$24M	$49M	$16M	$27M	$21M	$23M	$-31M	$-68M	$11M	$21M	$1M	$-8M
Stock Issued	$18M	$2M	$4M	$0	$0	$0	$4M	$0	$0	$11M	$0	$-1.0K	$-115.0K	$1M	$0	$0
Net Stock Activity	·	$2M	·	·	·	$0	·	·	·	$11M	·	·	·	·	·	·
Financing Cash Flow	$18M	$3M	$4M	$277.0K	$6.0K	$468.0K	$4M	$244.0K	$132.0K	$12M	$-43.0K	$135M	$18M	$2M	$127.0K	$654.0K
Net Change in Cash	$14M	$-303.0K	$1M	$-14M	$-4M	$13M	$-16M	$-6M	$-12M	$-2M	$-53M	$38M	$13M	$-6M	$-24M	$-30M
Taxes Paid	·	·	·	·	·	·	·	$0	·	·	$0	$0	·	·	$0	$0
Free Cash Flow	·	$-27M	·	·	·	$-38M	·	·	·	$-39M	·	·	·	·	·	·

Kârlılık 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1690.4%	-1096.4%	·	-1337.6%	-1784.0%	-1823.8%	·	-1889.2%	-1255.8%	-1893.9%	·	-61.8%	·	·	·	-803.4%
Net Margin	-1619.9%	-1046.5%	·	-1253.3%	-2028.4%	-1699.6%	·	-1713.6%	-1088.2%	-1697.6%	·	-42.3%	·	·	·	-806.8%
EBITDA Margin	-1690.4%	-1069.3%	·	-1337.6%	-1784.0%	-1774.2%	·	-1889.2%	-1255.8%	-1864.6%	·	-61.8%	·	·	·	-803.4%
ROA	-13.4%	-11.9%	·	-10.2%	-18.2%	-11.8%	·	-8.6%	-10.4%	-10.9%	·	-2.3%	·	·	·	-6.2%
ROE	-18.4%	-15.7%	·	-13.0%	-22.7%	-14.3%	·	-10.2%	-13.0%	-13.3%	·	-2.8%	·	·	·	-7.3%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.5	6.2	·	5.5	6.7	7.6	·	7.4	8.8	10.5	·	14.3	·	·	·	10.7
Quick Ratio		1.5	0.6	·	0.4	0.9	1.0	·	1.0	1.2	1.7	·	4.3	·	·	·	2.9

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1	·	·	·	0.0
Receivables Turnover		10.9	15.2	·	10.3	18.7	4.7	·	3.1	7.1	2.0	·	30.9	·	·	·	6.8

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.93	$1.05	·	$1.52	$1.78	$2.34	·	$3.11	$3.44	$3.80	·	$4.50	·	·	·	$5.31
Revenue / Share	$0.01	$0.03	·	$0.02	$0.03	$0.03	·	$0.02	$0.04	$0.03	·	$0.28	·	·	·	$0.05
Cash Flow / Share	·	$-0.28	·	·	·	$-0.40	·	·	·	$-0.42	·	·	·	·	·	·
Cash / Share	$0.25	$0.12	·	$0.12	$0.27	$0.32	·	$0.35	$0.42	$0.55	·	$1.18	·	·	·	$1.35
EPS (TTM)	$-1.08	$-1.42	·	$-1.70	$-1.78	$-1.62	·	$-1.58	$-1.32	$-1.38	·	$-1.50	$-1.82	$-1.66	·	$-1.11

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$10M	$11M	·	$9M	$9M	$10M	·	$11M	$33M	$33M	·	$35M	$15M	$14M	·	$13M
Net Income TTM	$-103M	$-133M	·	$-157M	$-164M	$-148M	·	$-148M	$-123M	$-115M	·	$-95M	$-111M	$-100M	·	$-91M
Market Cap	$187M	$184M	·	$218M	$117M	$85M	·	$177M	$148M	$464M	·	$423M	·	·	·	$643M
P/E	-1.6	-1.3	·	-1.4	-0.7	-0.6	·	-1.2	-1.2	-3.7	·	-3.2	-2.3	-3.2	·	-9.5
P/S	18.6	16.4	·	23.4	12.9	8.6	·	15.5	4.5	13.9	·	12.2	·	·	·	50.6
P/B	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	·	·	·	2.0
P / Tangible Book	1.9	1.8	·	1.5	0.7	0.4	·	0.6	0.5	1.4	·	1.1	1.0	1.2	·	2.0
P / Cash Flow	·	-6.8	·	·	·	-2.3	·	·	·	-12.5	·	·	·	·	·	·
Earnings Yield	-61.4%	-74.7%	·	-73.0%	-141.3%	-177.4%	·	-80.6%	-80.5%	-26.9%	·	-31.4%	-42.8%	-31.3%	·	-10.5%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$11M	$10M	$34M	$14M	$10M
Faaliyet Kâr Marjı %	-1329.4%	-1667.2%	-336.6%	-768.2%	-697.8%
Net Gelir	$-148M	$-149M	$-102M	$-99M	$-67M
Seyreltilmiş Hisse Başı Kâr	$-1.59	$-1.65	$-1.38	$-1.64	$-2.11

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	5.7	7.2	12.0	9.3	15.1
Cari Oran	0.5	0.5	1.8	2.1	9.4

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-112M	$-143M	$-105M	$-97M	$-35M

Kurumsal Sahipler (13F) 148 dosya · $89.6M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 148

Tutulan Değer $89.6M

Yeni pozisyonlar 26

Çıkan pozisyonlar 22

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
26 (-4 önceki Ç'ye göre)	22 (+11 önceki Ç'ye göre)	45 (+14 önceki Ç'ye göre)	28 (-10 önceki Ç'ye göre)	+10.5M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
BlackRock, Inc.	$13.755.883	7.815.843	15,36%	Hisse senetleri
Pfizer Inc	$7.879.924	4.690.431	8,80%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$7.407.080	4.208.568	8,27%	Hisse senetleri
VANGUARD GROUP INC	$6.843.676	4.304.198	7,64%	Hisse senetleri
MACKENZIE FINANCIAL CORP	$6.425.401	3.650.796	7,17%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$4.881.439	2.773.545	5,45%	Hisse senetleri
Kynam Capital Management, LP	$4.405.812	2.503.302	4,92%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$4.180.624	2.374.894	4,67%	Hisse senetleri
STATE STREET CORP	$2.873.929	1.632.914	3,21%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$2.483.287	1.410.958	2,77%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$1.841.451	1.046.279	2,06%	Hisse senetleri
TWO SIGMA ADVISERS, LP	$1.773.963	1.115.700	1,98%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$1.716.629	975.327	1,92%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.365.424	775.809	1,52%	Hisse senetleri
FMR LLC	$1.279.722	727.115	1,43%	Hisse senetleri
NORTHERN TRUST CORP	$1.254.819	712.965	1,40%	Hisse senetleri
MAVERICK CAPITAL LTD	$1.148.474	652.542	1,28%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.080.290	613.801	1,21%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$1.067.243	606.388	1,19%	Hisse senetleri
Qube Research & Technologies Ltd	$960.529	545.755	1,07%	Hisse senetleri
UBS Group AG	$910.573	517.371	1,02%	Hisse senetleri
72 Investment Holdings, LLC	$834.358	474.067	0,93%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$723.323	410.979	0,81%	Hisse senetleri
MARSHALL WACE, LLP	$661.205	375.686	0,74%	Hisse senetleri
Green Alpha Advisors, LLC	$641.210	364.324	0,72%	Hisse senetleri
PFM Health Sciences, LP	$624.249	354.687	0,70%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$568.260	322.875	0,63%	Hisse senetleri
Invesco Ltd.	$529.966	301.117	0,59%	Hisse senetleri
WELLS FARGO & COMPANY/MN	$525.035	298.315	0,59%	Hisse senetleri
XTX Topco Ltd	$473.716	269.157	0,53%	Hisse senetleri
Bruce & Co., Inc.	$440.000	250.000	0,49%	Hisse senetleri
Man Group plc	$422.516	240.066	0,47%	Hisse senetleri
Bank of New York Mellon Corp	$391.706	222.560	0,44%	Hisse senetleri
MILESTONE ASSET MANAGEMENT, LLC	$352.150	200.085	0,39%	Hisse senetleri
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$305.140	173.375	0,34%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$291.129	165.414	0,33%	Hisse senetleri
Susquehanna Portfolio Strategies, LLC	$279.131	158.597	0,31%	Hisse senetleri
Graham Capital Management, L.P.	$274.409	155.914	0,31%	Hisse senetleri
AMERICAN CENTURY COMPANIES INC	$247.421	140.580	0,28%	Hisse senetleri
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$232.320	132.000	0,26%	Hisse senetleri
Nuveen, LLC	$217.388	123.516	0,24%	Hisse senetleri
CITADEL ADVISORS LLC	$217.008	123.300	0,24%	Alım opsiyonu
Cubist Systematic Strategies, LLC	$216.135	92.762	0,24%	Hisse senetleri
LPL Financial LLC	$216.082	122.774	0,24%	Hisse senetleri
MORGAN STANLEY	$213.523	121.320	0,24%	Hisse senetleri
NANO CAP NEW MILLENNIUM GROWTH FUND L P	$206.800	117.500	0,23%	Hisse senetleri
DEUTSCHE BANK AG\	$157.652	89.575	0,18%	Hisse senetleri
Quadrature Capital Ltd	$156.603	88.979	0,17%	Hisse senetleri
CANADA PENSION PLAN INVESTMENT BOARD	$142.736	81.100	0,16%	Hisse senetleri
Keystone Financial Group	$142.252	80.825	0,16%	Hisse senetleri

Tüm 148 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 1 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 başvurular	25 Nisan 2025	5,00%	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 18 içeriden öğrenenler · 9 yöneticiler · 7 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Rachel E. Haurwitz	President and CEO	20 Şubat 2026 A	447.150	0	$0
Sriram Ryali	Chief Financial Officer	20 Şubat 2026 A	72.360	0	$0
Jason O'Byrne	Chief Financial Officer	20 Şubat 2024 A	59.224	0	$0
Timothy P Kelly	Chief Technology Officer	25 Şubat 2026 S	73.125	2	$-18.188
Tina M. Albertson	Chief Medical Officer	20 Şubat 2026 A	68.523	1	$-2.089
Ruhi Ahmad Khan	Chief Business Officer	20 Şubat 2026 A	104.998	1	$-13.598
Steven Kanner	Chief Scientific Officer	20 Şubat 2025 A	431.556	0	$0
Ryan Fischesser	VP of Finance and Controller	20 Kasım 2024 A	118.854	0	$0
Syed Ali-Aamir Rizvi	Chief Medical Officer	21 Şubat 2023 A	59.373	0	$0
Dara Richardson-Heron	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
Ran Zheng	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
Nancy Whiting	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
David Lee Johnson	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
Natalie Sacks	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
Scott Braunstein	Yönetim kurulu üyesi	20 Şubat 2026 A	·	0	$0
Barbara G Mcclung	·	20 Şubat 2026 A	481.564	1	$-13.598
Andrew Guggenhime	·	20 Şubat 2026 A	·	0	$0
FMR LLC	·	27 Temmuz 2021 C	1.464.775	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 15 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
OMFS · Invesco Exchange-Traded Self-Indexe…	0,08%	164.575 SH	02 Ekim 2026	Günlük
IWC · iShares Trust	0,03%	319.257 SH	11 Eylül 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	79.869 SH	19 Ağustos 2026	Günlük
IBB · iShares Trust	0,01%	670.052 SH	11 Eylül 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,01%	6.958 SH	02 Ekim 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	131.852 SH	02 Ekim 2026	Günlük
RSSL · Global X Funds	0,00%	43.883 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,00%	2.250.647 SH	11 Eylül 2026	Günlük
DFAS · Dimensional ETF Trust	0,00%	255.338 NS	31 Temmuz 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	74.931 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.113.215 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	3.013.973 SH	19 Ağustos 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,00%	524.917 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	9.015 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	875.712 SH	11 Eylül 2026	Günlük

CRBU Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 13 analist AL

Medyan hedef $10.00 +719,7%

5 38,5% Güçlü Al

7 53,8% Al

1 7,7% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

7 analist · 2026-10-02

Ortalama hedef $11.86 +871,9%

← Tüm hedeflerin altında Mevcut fiyat $1.22

Düşük$4.00 Ortalama$11.86 Yüksek$32.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
CRBU	$151M	-1.0	11.7%	-1327.4%	-102.8%	·
KRRO	$75M	-0.6	181.5%	-1834.5%	-140.8%	·
OTLK	$57M	-0.6	·	-4416.2%	193.1%	4.0%
FHTX	$306M	-4.6	36.8%	-240.3%	80.2%	·
PMVP	$67M	-0.8	-40.5%	-1226.8%	-63.4%	·
RNA	$10.91B	-14.5	72.1%	-3650.4%	-47.5%	·
SPRB	$120M	-1.7	-51.3%	·	-139.9%	·
TNYA	$154M	-1.2	·	·	-81.2%	·
CBUS	·	-0.6	-14.6%	-3492.3%	-223.0%	·
INO	$120M	-1.0	-70.0%	-130000.0%	-322.8%	·

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

CRBU Caribou Biosciences, Inc. - Common Stock

CRBU Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

CRBU Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Kurumsal Sahipler (13F) 148 dosya · $89.6M toplam · Tarih itibarıyla 30 Haziran 2026

Aktivistler ve %5+ sahipler 1 pozisyon

Şirket yöneticileri 18 içeriden öğrenenler · 9 yöneticiler · 7 yönetim kurulu üyeleri

ETF sahipliği 15 ETF'ler tarafından tutuluyor

CRBU Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar